Bisphenol A is an industrial chemical widely used in plastic products with a consequent exposure to humans. To assess whether exposure to bisphenol A is associated with renal disease, we searched for low-grade albuminuria in 3055 Chinese adults in the Shanghai metropolitan area aged 40 years or older. Using a value for urinary albumin-tocreatinine ratios o30 mg/g, we examined its association with urinary bisphenol A. Participants in the highest compared to the lowest quartile of urinary bisphenol A concentrations were significantly more likely to have low-grade albuminuria. Multivariate stepwise linear regression analysis, adjusted for potential confounding factors, showed that urinary bisphenol A was an independent determinant of the urinary albumin-to-creatinine ratio significantly associated with an increased risk of low-grade albuminuria with an adjusted odds ratio of 1.23 for the highest compared to the lowest concentration quartiles. This association was not modified by conventional risk factors such as age, gender, smoking, alcohol consumption, body mass index, hypertension, diabetes, and the estimated glomerular filtration rate. There was no significant relationship between bisphenol A and combined micro-and macroalbuminuria. Thus, our study lends support to a potential relation between bisphenol A exposure and an increased risk of low-grade albuminuria.
Microalbuminuria, conventionally defined as a urinary albumin excretion (spot urine albumin-to-creatinine ratio) of 30 to o300 mg/g, 1 is recognized as a risk factor for cardiovascular morbidity and mortality. [2] [3] [4] [5] There is growing evidence from prospective studies that urinary albuminto-creatinine ratio levels less than the current microalbuminuria threshold (low-grade albuminuria) are associated with an increased risk of incident cardiovascular diseases. 6, 7 Bisphenol A, which is widely used to produce polycarbonate plastic and epoxy resins and usually found in water bottles and food containers, is one of the environmental endocrine disruptors. 8, 9 Bisphenol A has estrogen-mimicking effect and may interact with estrogen receptors. [10] [11] [12] Humans are extensively exposed to bisphenol A. The US Centers for Disease Control and Prevention found bisphenol A was in the urine of 95% of US adults. 13, 14 Animal studies have suggested that exposure to bisphenol A might lead to abnormal metabolism of glucose and lipids, and exacerbate the development of cardiovascular diseases. [15] [16] [17] [18] [19] However, epidemiological data about the relationship between bisphenol A exposure and human health were surprisingly lacking. Recently, in the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and 2005-2006 , it was found that higher urinary bisphenol A concentrations were associated with various diseases including cardiovascular diseases and type 2 diabetes. 20, 21 However, no studies have examined the associations between low-grade albuminuria, an early marker of cardiovascular diseases, and bisphenol A exposure.
In this study, we aim to assess the association between bisphenol A exposure and low-grade albuminuria in a large sample of Chinese adults.
(interquartile range: 0.48-1.44 ng/ml). Approximately 11% of the participants reported having cardiovascular diseases (including coronary heart disease, angina, and myocardial infarction) and 142 (4.1%) reported taking angiotensinconverting enzyme inhibitor or angiotensin receptor blocker drugs. In addition, there were 640 participants with estimated glomerular filtration rate p90 ml/min per 1.73 m 2 . According to the 75-g oral glucose tolerance test (OGTT) diagnosis criteria, 1087 (31.5%) had diabetes, 748 (21.6%) had impaired glucose regulation, and 1588 (46.0%) had normal glucose regulation.
There were 333 participants with microalbuminuria and 67 with macroalbuminuria. Among participants without micro-and macroalbuminuria, the quartile ranges of urinary albumin-to-creatinine ratio were 0-2.50, 2.51-5.03, 5.04-9.70, and 9.71-29.9 mg/g. Compared with those who had normal urinary albumin excretion, those with low-grade albuminuria (defined as urinary albumin-to-creatinine ratio between 9.71 and 29.9 mg/g) had significantly higher urinary bisphenol A levels (0.95 with interquartile range 0.54-1.72 vs. 0.79 with interquartile range 0.46-1.37 ng/ml; Po0.0001). However, there was no significant difference in urinary bisphenol A between the group with normal urinary albumin excretion and that with micro-and macroalbuminuria.
Association between bisphenol A and low-grade albuminuria
To evaluate the association between bisphenol A and lowgrade albuminuria, a total of 3055 participants without micro-and macroalbuminuria were included in the analysis.
The clinical and biochemical characteristics according to the quartiles of bisphenol A are presented in Table 2 . Compared with the participants in the lowest quartile (o0.48 ng/ml), those in the highest quartile of urinary bisphenol A concentration (X1.45 ng/ml) were more likely to be men, were younger, had higher proportions of current smokers and drinkers, and higher body mass index, waist circumference, estimated glomerular filtration rate, fasting plasma glucose, but had lower systolic blood pressure, total cholesterol, and high-density lipoprotein cholesterol (all Po0.05). The median of urinary albumin-to-creatinine ratio in the highest quartile of urinary bisphenol A (6.41, interquartile range: 3.11-11.47 mg/g) was significantly higher than that in the lowest quartile (4.42, interquartile range: 2.30-8.50 mg/g) (Po0.0001). Participants in the highest quartiles of urinary bisphenol A were more likely to have low-grade albuminuria than those in the lowest quartile (30.9% vs. 21.1%, Po0.0001) ( Table 2) .
As shown in Table 3 , Pearson's correlation analyses revealed that age, sex, current smoking, the use of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker drugs, body mass index, waist circumference, systolic blood pressure, diastolic blood pressure, estimated glomerular filtration rate, triglycerides, total cholesterol, high-density lipoprotein cholesterol, fasting plasma glucose, post-loading plasma glucose, hemoglobin A1c, index of homeostasis model assessment of insulin resistance (HOMA-IR), highsensitivity C-reactive protein, and urinary bisphenol A were significantly correlated with urinary albumin-to-creatinine A1c, high-sensitivity C-reactive protein, and bisphenol A were independent determinants of urinary albumin-tocreatinine ratio. In the univariable logistic regression model, participants in the highest quartile of urinary bisphenol A were more likely to have low-grade albuminuria compared with those in the lowest quartile (odds ratio (OR): 1.68, 95% confidence intervals (95% CI) 1.33-2.12; Po0.0001), and those in the third quartile (0.82pbisphenol Ao1.45 ng/ml) were also more likely to have low-grade albuminuria (OR: 1.31, 95% CI 1.03-1.66; P ¼ 0.028). The test for the trend was significant (P for trend o0.0001). After adjusting for age, sex, and body mass index, participants in the highest and third quartiles were still more likely to have low-grade albuminuria compared with those in the lowest quartile, respectively (adjusted OR: 1.80, 95% CI 1.41-2.29, Po0.0001; and 1.39, 95% CI 1.09-1.78, P ¼ 0.0079). Further adjustments for other potential confounding factors including age, sex, smoking and drinking status, the use of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker drugs, body mass index, systolic blood pressure, diastolic blood pressure, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, estimated glomerular filtration rate, fasting plasma glucose, post-loading plasma glucose, hemoglobin A1c, HOMA-IR, and high-sensitivity C-reactive protein did not materially change the magnitudes of the associations (adjusted ORs for the highest vs. the lowest quartile: 1.23, 95% CI 1.13-1.34, Po0.0001, and for the third vs. the lowest quartile: 1.20, 95% CI 1.06-1.37, P ¼ 0.005).
The tests for the trend in the multivariable analyses were all significant (P for trend o0.0001) (Table 4) .
Finally, we conducted stratified analyses to determine the ORs of low-grade albuminuria with each 1 s.d. increase in log-bisphenol A in subgroups of the strata variables. According to stratified analyses, the associations between urinary bisphenol A concentration and the risk of low-grade albuminuria were significant in both age strata (o60 and X60 years), both sex strata (male and female), both body mass index strata (o25 and X25 kg/m 2 ), both smoking status (yes and no), both drinking status (yes and no), both hypertension strata (yes and no), both diabetes strata according to the OGTT diagnosis criteria (yes and no), and both estimated glomerular filtration rate strata (o90 and X90 ml/min per 1.73 m 2 ). Nevertheless, interactions between urinary bisphenol A and these risk factors were not significant (P40.05) (Figure 1) .
The associations between urinary bisphenol A concentration and the risk of low-grade albuminuria were not significant in those with high-sensitivity C-reactive protein X3.0 mg/l (N ¼ 297 among these 3055). Test for the interaction between urinary bisphenol A and high-sensitivity C-reactive protein was also not significant.
Association between bisphenol A and greater-grade albuminuria
The 400 participants with micro-or macroalbuminuria were included in the analysis. No significant relationships between bisphenol A and combined micro-and macroalbuminuria were observed (adjusted ORs for the highest vs. the lowest quartile: 1.24, 95% CI 0.87-1.77; for the third vs. the lowest quartile: 1.07, 95% CI 0.75-1.53; and for the second vs. the lowest quartile: 1.10, 95% CI 0.87-1.77) ( Table 5) .
DISCUSSION
In this study of Chinese adults with the urinary albuminto-creatinine ratio less than the current microalbuminuria threshold, we found that higher urinary bisphenol A concentrations were significantly associated with an increased risk of low-grade albuminuria, independent of conventional risk factors.
Although animal studies have shown that bisphenol A was an endocrine disruptor and had an estrogen-mimicking effect, 11, 22, 23 epidemiological studies on the relationship between bisphenol A exposure and human diseases are sparse. Recently, Lang et al. 20 performed a cross-sectional analysis in 1,500 individuals from the NHANES 2003-2004. They found that higher urinary bisphenol A concentrations were associated with various diseases including cardiovascular diseases. A later updated analysis by the same 21 However, the supporting data from other populations are still lacking.
Previous studies have confirmed that there is an increased risk of cardiovascular diseases and death associated with microalbuminuria. [24] [25] [26] [27] [28] Recent studies demonstrated that urinary albumin excretion less than the current microalbuminuria threshold also significantly predicted cardiovascular diseases. 5, 7, 29, [30] [31] [32] [33] [34] The data from the Framingham Heart Study indicated that low levels of urinary albumin excretion less than the current microalbuminuria threshold (30 mg/g) predicted a more rapid progression toward We defined participants with normal urinary albumin excretion as 0 (n=2291) and those with combined micro-(n=333) and macroalbuminuria (n=67) as 1. Model 1: unadjusted. Model 2: adjusted for age, sex, and body mass index. Model 3: adjusted for all the potential confounding factors including age, sex, smoking and drinking status, use of ACEI or ARB drugs, body mass index, systolic blood pressure, diastolic blood pressure, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, estimated glomerular filtration rate, fasting plasma glucose, post-loading plasma glucose, hemoglobin A1c, HOMA-IR, and high-sensitivity C-reactive protein.
vascular diseases in healthy subjects, and, in the long term, an increased incidence of cardiovascular disease events. 29, 35 In another study, Arnlöv et al. 29 reported that the cutoff for an elevated cardiovascular event rate was 3.9 mg/g of urinary albumin-to-creatinine ratio for men and 7.5 mg/g of urinary albumin-to-creatinine ratio for women. Data from the HOPE study showed that the risk of cardiovascular events increased with the urinary albumin-to-creatinine ratio and suggested that any degree of albuminuria is a risk factor for cardiovascular diseases. 34 The MONICA/KORA Augsburg Echocardiographic Substudy also reported that low-grade albuminuria with urinary albumin-to-creatinine ratio of 4.0-10.0 mg/g was associated with an increased cardiovascular risk. 32 Therefore, low-grade albuminuria is well established as one of the risk factors for cardiovascular diseases, suggesting that urinary bisphenol A might be related to cardiovascular risks.
There is still no well-agreed explanation of the mechanisms for the effect of bisphenol A on early urine albumin excretion, but it is now widely accepted that bisphenol A not only has the efficacy of estradiol but is also equally potent with regard to several of its effects. [36] [37] [38] Bisphenol A was considered a weak environmental estrogen because of its relatively low affinity for the estrogen receptors compared with estradiol. 36, 37, 39, 40 Bisphenol A has a rapid, non-genomic promoting effect by binding to not a classical estrogen receptors, but rather G-protein-coupled non-classical membrane estrogen receptors, bisphenol A also can promote cell proliferation by activating protein kinase A/cyclic AMPresponsive element binding protein and protein kinase G rapid signaling pathways in various cell types, including endothelial cells. 38 Studies in both diabetic patients and general individuals indicated that elevated urinary albumin excretion was associated with abnormalities in endothelial function. [41] [42] [43] [44] On the basis of the results of these studies, the non-genomic promoting effect on endothelial function by bisphenol A may have a potential role in affecting urinary albumin excretion.
In addition, by decreasing antioxidant enzymes and increasing hydrogen peroxide and lipid peroxidation, bisphenol A induces oxidative stress, which takes an important part in the pathogenesis of endothelial injury and abnormal albuminuria. 1, 5, 14 In addition, bisphenol A has been known to increase insulin mimics of estradiol and influence the insulin-secreting beta cells and glucagon-secreting alpha cells of the pancreas, and then leads to hyperinsulinemia and finally to insulin resistance, a factor contributing to the development of elevated urinary albumin excretion. 45, 46 In addition, as low-grade albuminuria is a predictor for chronic kidney diseases or diabetic nephropathy, it is possible that bisphenol A exposure might also contribute to renal disease progression. 30 However, no significant relationships between bisphenol A and combined micro-and macroalbuminuria were found in our study. As micro-and macroalbuminuria were greater-grade manifestation of renal injury, it is likely that there are more metabolic risk factors associated with micro-and macroalbuminuria, some of which might veil the effect of bisphenol A. However, the underlying reason remains unexplained and requires further exploration.
Our study is the first to examine the association between bisphenol A exposure and low-grade albuminuria in Chinese adults. The strengths of our investigation include the large community-based cohort of individuals. In addition, we have measured a wide spectrum of lifestyle and biochemical risk factors, which allow a careful control for the potential confounding effects in the analyses.
There are several limitations to be considered. First, because of the cross-sectional nature of this study, we cannot conclude a causal relationship between bisphenol A and lowgrade albuminuria. We will pursue to examine the prospective associations of bisphenol A with low-grade albuminuria and cardiovascular risk in future when the data are available. Second, urinary albumin excretion was assessed in a single urine sample. We acknowledge that a 24-h urine sample or three samples from 3 consecutive days would provide more stable measures for urinary albumin excretion. 26 However, it was reported that the use of spot specimens for urinary albumin-to-creatinine ratio was more convenient for a large cohort sample and well agreed with 24-h urinary albumin excretion, and could be used as a reliable alternative to 24-h urinary albumin excretion or multiple samples in large epidemiological research. 47, 48 In conclusion, this study demonstrated that bisphenol A exposure was associated with an increased risk of low-grade albuminuria in Chinese adults. Further follow-up studies are warranted to validate our findings.
MATERIALS AND METHODS Study design and participants
A cross-sectional study was conducted to investigate the association between bisphenol A exposure and the human health outcomes in Chinese adults. The study population, design, and protocols have been described previously. 49 Briefly, in June-July 2008, we performed an investigation in a population selected from Songnan Community, Baoshan District, Shanghai metropolitan area, China. As our major interest was focused on the effects of bisphenol A exposure on chronic diseases, we conducted the investigation in residents aged 40 years or older. A total of 10,185 participants were included in the screening examination. Participants were classified into one of three groups according to fasting plasma glucose levels: normal glucose regulation (fasting plasma glucoseo5.6 mmol/l and without diabetes history), impaired glucose regulation (5.6pfasting plasma glucoseo7.0 mmol/l and without diabetes history), and diabetes (fasting plasma glucoseX7.0 mmol/l or with history of diabetes). In June-August 2009, participants were randomly selected from these groups for further investigation, which included a detailed questionnaire, anthropometric measurement, a 75-g OGTT, and blood and urine sampling. Our selection was based on a ratio of 1.0 (diabetes):1.2 (impaired glucose regulation):1.44 (normal glucose regulation) because subjects with lower glucose levels might have a lower participation rate than those with higher glucose levels. Among 3455 study participants with blood and urine samples included in the second survey, 400 participants with macroalbuminuria (urinary albumin-to-creatinine ratioX300 mg/g, n ¼ 67) or microalbuminuria (30 mg/gpurinary albumin-to-creatinine ratio o300 mg/g, n ¼ 333) were excluded from the analysis for risk of low-grade albuminuria. Thus, 3055 participants with urinary albumin-to-creatinine ratio less than the current microalbuminuria threshold (30 mg/g) were included in the current analysis for the association of low-grade albuminuria with bisphenol A exposure. The participants (3055 subjects) and the nonparticipants (7130 subjects) were similar in characteristics such as sex and age.
All study participants provided written informed consent, and the Committee on Human Research at the Jiao-Tong University School of Medicine Rui-Jin Hospital approved the study protocol.
Clinical evaluation
The information of sociodemographics, medical history, family history, and lifestyle factors was collected through face-to-face interviews by trained personnel. All participants underwent a physical examination including measurement of weight, height, waist circumference, systolic blood pressure, and diastolic blood pressure. Blood pressure was measured at nondominant arm in a seated position after a 5-min rest, using an automated electronic device (OMRON Model HEM-752 FUZZY, Omron, Dalian, China). Three measurements were taken 1 min apart, and an average of the three was used in analysis. Body mass index was calculated by dividing weight (in kg) by the square of height (in meters).
Subjects were admitted after an overnight fast of 410 h and underwent a 75-g OGTT. The fasting and OGTT 2-h venous blood samples were collected into a routine tube, respectively, and were immediately processed by centrifugation at 4 1C for 5 min at 4000 relative centrifugal force. Fasting plasma glucose, post-loading plasma glucose, fasting and post-loading serum insulin concentrations, serum creatinine, lipids profile including triglycerides, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, and high-sensitivity C-reactive protein were detected within 1 h of collection. Another anticoagulated venous blood (heparin) was collected for measurement of hemoglobin A1c within 4 h of collection.
Venous plasma glucose level was measured by glucose oxidase method (ADVIA-1650 Chemistry System, Bayer, Leverkusen, Germany), hemoglobin A1c was measured by high-performance liquid chromatography (BIO-RAD, Hercules, CA), and serum insulin concentrations were measured by an electrochemiluminescence assay (Roche-Diagnostics, Basel, Switzerland). Serum creatinine, triglycerides, total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, and high-sensitivity C-reactive protein were measured with an autoanalyzer (ADVIA-1650 Chemistry System, Bayer). HOMA-IR was calculated as fasting insulin (mIU/ml) Â fasting plasma glucose (mmol/l)/22.5.
Estimated glomerular filtration rate expressed in ml/min per 1.73 m 2 was calculated by the abbreviated modification of diet in renal disease formula recalibrated for Chinese: 50 estimated glomerular filtration rate ¼ 186 Â (serum creatinine value Â 0.011) À1.154 Â (age) À0.203 Â (0.742 if female) Â 1.233, where serum creatinine value is serum creatinine expressed as mmol/l and 1.233 is the adjusting coefficient for Chinese.
Urinary albumin excretion
The single-void first morning urine samples were collected into two bisphenol A-free urine containers. One was assessed for the urinary albumin-to-creatinine ratio within 1 h after sample collection. Another was stored at À70 1C within 4 h after sample collection until other measurements were recorded.
Urinary albumin concentration was determined by immunoturbidimetry (Beijia Biochemistry, Shanghai, China), and urinary creatinine concentration was measured by a modified Jaffe method on an automatic analyzer (Beckman LX/20, Brea, CA). Urinary albumin-to-creatinine ratio was calculated by dividing the urinary albumin concentrations by the urinary creatinine concentrations and expressed in mg/g.
The definition of low-grade albuminuria was according to the highest quartile of urinary albumin-to-creatinine ratio in participants without micro-and macroalbuminuria. Quartile ranges for urinary albumin-to-creatinine ratio were as follows: 0-2.50, 2.51-5.03, 5.04-9.70, and 9.71-29.9 mg/g.
Quantification of urinary bisphenol A concentration
The urine samples stored at À70 1C within 4 h after sample collection were thawed and measured for total (free and conjugated) urinary bisphenol A concentration at the Shanghai Institute of Materia Medica, Chinese Academy of Sciences, and determined after enzymatic hydrolysis by a sensitive and selective liquid chromatography-tandem mass spectrometry method as previously described. 49 The intra-and inter-day relative s.d., calculated from quality control samples (0.80, 10.0, and 80.0 ng/ml), were both below 8.7%. The inter-day relative error as determined from quality control samples was within 2.5%. The lower limit of detection for bisphenol A concentrations, at which both precision and accuracy were o9.1%, was 0.30 ng/ml. The results of stability experiments showed that no significant degradation occurred during sample incubation, chromatography, and extraction processes for bisphenol A in urine samples (deviating no 47.4% at low and high nominal concentrations). The analytical data demonstrated excellent reproducibility, specificity, sensitivity, and precision for measurement of urinary bisphenol A concentrations.
Statistical analysis
There were large variations in bisphenol A concentrations in the urinary samples, and the data were not normally distributed. The bisphenol A concentrations were logarithmically transformed, and median with interquartile range and quartiles were used to describe the results. Bisphenol A results less than the lower limit of detection (n ¼ 369/3055) were replaced with a value equal to the lower limit of detection divided by 2 in order to distinguish a non-detectable laboratory test result from a measured laboratory test result. 51 Statistical analysis was performed with SAS 8.1 (SAS Institute, Cary, NC). Continuous variables were summarized by means and s.d. for normally distributed data or medians and interquartile ranges for non-normally distributed data. Urinary albumin-tocreatinine ratio, triglycerides, fasting plasma glucose, post-loading plasma glucose, hemoglobin A1c, HOMA-IR, and high-sensitivity C-reactive protein levels were logarithmically transformed to achieve a normal distribution. All categorical parameters were summarized as numbers and proportions.
Pearson's correlation coefficients of urinary albumin-tocreatinine ratio with potential confounding factors were calculated. The variables that were significant at Po0.20 level in Pearson's correlations were put into the multiple stepwise linear regression models to identify the independent determinants of urinary albumin-to-creatinine ratio.
Univariable logistic regression models were first fitted to evaluate the crude association between bisphenol exposure and low-grade albuminuria. In the multivariable logistic regression models, we adjusted for the potential confounding factors including age, sex, smoking and drinking status, the use of angiotensinconverting enzyme inhibitor or angiotensin receptor blocker drugs, body mass index, systolic blood pressure, diastolic blood pressure, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, estimated glomerular filtration rate, fasting plasma glucose, post-loading plasma glucose, hemoglobin A1c, HOMA-IR, and high-sensitivity C-reactive protein. Urinary bisphenol A concentration was analyzed as both a continuous (in the unit of s.d. of log-bisphenol A) and a categorical variable (in quartiles) in separate analyses.
We further performed stratified analyses on the associations between bisphenol A exposure and the risk of low-grade albuminuria by the major risk factors including age, sex, smoking and drinking status, body mass index, hypertension, diabetes according to OGTT diagnosis criteria, hemoglobin A1c, estimated glomerular filtration rate, and high-sensitivity C-reactive protein.
The interaction tests were conducted by introducing the crossproduct terms of the stratum variables and bisphenol A in logistic regression models.
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